Zika Virus Infection Drug Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zika Virus Infection Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Zika Virus Infection Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Zika Virus Infection Drug Market Perspective (2017-2028)
2.2 Zika Virus Infection Drug Growth Trends by Region
2.2.1 Zika Virus Infection Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Zika Virus Infection Drug Historic Market Size by Region (2017-2022)
2.2.3 Zika Virus Infection Drug Forecasted Market Size by Region (2023-2028)
2.3 Zika Virus Infection Drug Market Dynamics
2.3.1 Zika Virus Infection Drug Industry Trends
2.3.2 Zika Virus Infection Drug Market Drivers
2.3.3 Zika Virus Infection Drug Market Challenges
2.3.4 Zika Virus Infection Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zika Virus Infection Drug Players by Revenue
3.1.1 Global Top Zika Virus Infection Drug Players by Revenue (2017-2022)
3.1.2 Global Zika Virus Infection Drug Revenue Market Share by Players (2017-2022)
3.2 Global Zika Virus Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Zika Virus Infection Drug Revenue
3.4 Global Zika Virus Infection Drug Market Concentration Ratio
3.4.1 Global Zika Virus Infection Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zika Virus Infection Drug Revenue in 2021
3.5 Zika Virus Infection Drug Key Players Head office and Area Served
3.6 Key Players Zika Virus Infection Drug Product Solution and Service
3.7 Date of Enter into Zika Virus Infection Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Zika Virus Infection Drug Breakdown Data by Type
4.1 Global Zika Virus Infection Drug Historic Market Size by Type (2017-2022)
4.2 Global Zika Virus Infection Drug Forecasted Market Size by Type (2023-2028)
5 Zika Virus Infection Drug Breakdown Data by Application
5.1 Global Zika Virus Infection Drug Historic Market Size by Application (2017-2022)
5.2 Global Zika Virus Infection Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Zika Virus Infection Drug Market Size (2017-2028)
6.2 North America Zika Virus Infection Drug Market Size by Country (2017-2022)
6.3 North America Zika Virus Infection Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Zika Virus Infection Drug Market Size (2017-2028)
7.2 Europe Zika Virus Infection Drug Market Size by Country (2017-2022)
7.3 Europe Zika Virus Infection Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Zika Virus Infection Drug Market Size (2017-2028)
8.2 Asia-Pacific Zika Virus Infection Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Zika Virus Infection Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Zika Virus Infection Drug Market Size (2017-2028)
9.2 Latin America Zika Virus Infection Drug Market Size by Country (2017-2022)
9.3 Latin America Zika Virus Infection Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Zika Virus Infection Drug Market Size (2017-2028)
10.2 Middle East & Africa Zika Virus Infection Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Zika Virus Infection Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Company Detail
11.1.2 Emergent BioSolutions Business Overview
11.1.3 Emergent BioSolutions Zika Virus Infection Drug Introduction
11.1.4 Emergent BioSolutions Revenue in Zika Virus Infection Drug Business (2017-2022)
11.1.5 Emergent BioSolutions Recent Development
11.2 Valneva
11.2.1 Valneva Company Detail
11.2.2 Valneva Business Overview
11.2.3 Valneva Zika Virus Infection Drug Introduction
11.2.4 Valneva Revenue in Zika Virus Infection Drug Business (2017-2022)
11.2.5 Valneva Recent Development
11.3 Moderna
11.3.1 Moderna Company Detail
11.3.2 Moderna Business Overview
11.3.3 Moderna Zika Virus Infection Drug Introduction
11.3.4 Moderna Revenue in Zika Virus Infection Drug Business (2017-2022)
11.3.5 Moderna Recent Development
11.4 Novavax
11.4.1 Novavax Company Detail
11.4.2 Novavax Business Overview
11.4.3 Novavax Zika Virus Infection Drug Introduction
11.4.4 Novavax Revenue in Zika Virus Infection Drug Business (2017-2022)
11.4.5 Novavax Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Zika Virus Infection Drug Introduction
11.5.4 Johnson & Johnson Revenue in Zika Virus Infection Drug Business (2017-2022)
11.5.5 Johnson & Johnson Recent Development
11.6 Themis Bioscience
11.6.1 Themis Bioscience Company Detail
11.6.2 Themis Bioscience Business Overview
11.6.3 Themis Bioscience Zika Virus Infection Drug Introduction
11.6.4 Themis Bioscience Revenue in Zika Virus Infection Drug Business (2017-2022)
11.6.5 Themis Bioscience Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Zika Virus Infection Drug Introduction
11.7.4 Sanofi Revenue in Zika Virus Infection Drug Business (2017-2022)
11.7.5 Sanofi Recent Development
11.8 IMV
11.8.1 IMV Company Detail
11.8.2 IMV Business Overview
11.8.3 IMV Zika Virus Infection Drug Introduction
11.8.4 IMV Revenue in Zika Virus Infection Drug Business (2017-2022)
11.8.5 IMV Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Detail
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Zika Virus Infection Drug Introduction
11.9.4 Takeda Pharmaceutical Revenue in Zika Virus Infection Drug Business (2017-2022)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 CaroGen
11.10.1 CaroGen Company Detail
11.10.2 CaroGen Business Overview
11.10.3 CaroGen Zika Virus Infection Drug Introduction
11.10.4 CaroGen Revenue in Zika Virus Infection Drug Business (2017-2022)
11.10.5 CaroGen Recent Development
11.11 GeoVax
11.11.1 GeoVax Company Detail
11.11.2 GeoVax Business Overview
11.11.3 GeoVax Zika Virus Infection Drug Introduction
11.11.4 GeoVax Revenue in Zika Virus Infection Drug Business (2017-2022)
11.11.5 GeoVax Recent Development
11.12 Tychan
11.12.1 Tychan Company Detail
11.12.2 Tychan Business Overview
11.12.3 Tychan Zika Virus Infection Drug Introduction
11.12.4 Tychan Revenue in Zika Virus Infection Drug Business (2017-2022)
11.12.5 Tychan Recent Development
11.13 Inovio Pharmaceuticals
11.13.1 Inovio Pharmaceuticals Company Detail
11.13.2 Inovio Pharmaceuticals Business Overview
11.13.3 Inovio Pharmaceuticals Zika Virus Infection Drug Introduction
11.13.4 Inovio Pharmaceuticals Revenue in Zika Virus Infection Drug Business (2017-2022)
11.13.5 Inovio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Zika Virus Infection Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Zika Virus Infection Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Zika Virus Infection Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Zika Virus Infection Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Zika Virus Infection Drug Market Share by Region (2017-2022)
Table 8. Global Zika Virus Infection Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Zika Virus Infection Drug Market Share by Region (2023-2028)
Table 10. Zika Virus Infection Drug Market Trends
Table 11. Zika Virus Infection Drug Market Drivers
Table 12. Zika Virus Infection Drug Market Challenges
Table 13. Zika Virus Infection Drug Market Restraints
Table 14. Global Zika Virus Infection Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Zika Virus Infection Drug Market Share by Players (2017-2022)
Table 16. Global Top Zika Virus Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Virus Infection Drug as of 2021)
Table 17. Ranking of Global Top Zika Virus Infection Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Zika Virus Infection Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Zika Virus Infection Drug Product Solution and Service
Table 21. Date of Enter into Zika Virus Infection Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Zika Virus Infection Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Zika Virus Infection Drug Revenue Market Share by Type (2017-2022)
Table 25. Global Zika Virus Infection Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Zika Virus Infection Drug Revenue Market Share by Type (2023-2028)
Table 27. Global Zika Virus Infection Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Zika Virus Infection Drug Revenue Market Share by Application (2017-2022)
Table 29. Global Zika Virus Infection Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Zika Virus Infection Drug Revenue Market Share by Application (2023-2028)
Table 31. North America Zika Virus Infection Drug Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Zika Virus Infection Drug Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Zika Virus Infection Drug Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Zika Virus Infection Drug Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Zika Virus Infection Drug Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Zika Virus Infection Drug Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Zika Virus Infection Drug Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Zika Virus Infection Drug Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Zika Virus Infection Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Zika Virus Infection Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Emergent BioSolutions Company Detail
Table 42. Emergent BioSolutions Business Overview
Table 43. Emergent BioSolutions Zika Virus Infection Drug Product
Table 44. Emergent BioSolutions Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 45. Emergent BioSolutions Recent Development
Table 46. Valneva Company Detail
Table 47. Valneva Business Overview
Table 48. Valneva Zika Virus Infection Drug Product
Table 49. Valneva Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 50. Valneva Recent Development
Table 51. Moderna Company Detail
Table 52. Moderna Business Overview
Table 53. Moderna Zika Virus Infection Drug Product
Table 54. Moderna Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 55. Moderna Recent Development
Table 56. Novavax Company Detail
Table 57. Novavax Business Overview
Table 58. Novavax Zika Virus Infection Drug Product
Table 59. Novavax Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 60. Novavax Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Zika Virus Infection Drug Product
Table 64. Johnson & Johnson Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Themis Bioscience Company Detail
Table 67. Themis Bioscience Business Overview
Table 68. Themis Bioscience Zika Virus Infection Drug Product
Table 69. Themis Bioscience Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 70. Themis Bioscience Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Zika Virus Infection Drug Product
Table 74. Sanofi Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. IMV Company Detail
Table 77. IMV Business Overview
Table 78. IMV Zika Virus Infection Drug Product
Table 79. IMV Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 80. IMV Recent Development
Table 81. Takeda Pharmaceutical Company Detail
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Zika Virus Infection Drug Product
Table 84. Takeda Pharmaceutical Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. CaroGen Company Detail
Table 87. CaroGen Business Overview
Table 88. CaroGen Zika Virus Infection Drug Product
Table 89. CaroGen Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 90. CaroGen Recent Development
Table 91. GeoVax Company Detail
Table 92. GeoVax Business Overview
Table 93. GeoVax Zika Virus Infection DrugProduct
Table 94. GeoVax Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 95. GeoVax Recent Development
Table 96. Tychan Company Detail
Table 97. Tychan Business Overview
Table 98. Tychan Zika Virus Infection DrugProduct
Table 99. Tychan Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 100. Tychan Recent Development
Table 101. Inovio Pharmaceuticals Company Detail
Table 102. Inovio Pharmaceuticals Business Overview
Table 103. Inovio Pharmaceuticals Zika Virus Infection DrugProduct
Table 104. Inovio Pharmaceuticals Revenue in Zika Virus Infection Drug Business (2017-2022) & (US$ Million)
Table 105. Inovio Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Zika Virus Infection Drug Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Zika Virus Infection Drug Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Homecare Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Zika Virus Infection Drug Report Years Considered
Figure 10. Global Zika Virus Infection Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Zika Virus Infection Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Zika Virus Infection Drug Market Share by Region: 2021 VS 2028
Figure 13. Global Zika Virus Infection Drug Market Share by Players in 2021
Figure 14. Global Top Zika Virus Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Virus Infection Drug as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Zika Virus Infection Drug Revenue in 2021
Figure 16. North America Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Zika Virus Infection Drug Market Share by Country (2017-2028)
Figure 18. United States Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Zika Virus Infection Drug Market Share by Country (2017-2028)
Figure 22. Germany Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Zika Virus Infection Drug Market Share by Region (2017-2028)
Figure 30. China Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Zika Virus Infection Drug Market Share by Country (2017-2028)
Figure 38. Mexico Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Zika Virus Infection Drug Market Share by Country (2017-2028)
Figure 42. Turkey Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Zika Virus Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Emergent BioSolutions Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 45. Valneva Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 46. Moderna Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 47. Novavax Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 48. Johnson & Johnson Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 49. Themis Bioscience Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 50. Sanofi Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 51. IMV Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 53. CaroGen Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 54. GeoVax Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 55. Tychan Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 56. Inovio Pharmaceuticals Revenue Growth Rate in Zika Virus Infection Drug Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Industry Market Size
